All news

SOPH director files to sell 9,838 shares under 10b5-1 plan

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

SOPHiA GENETICS Director Ross J. Muken filed a Form 144 for the proposed sale of 9,838 common shares, valued at approximately $79,392.66, under a Rule 10b5-1 trading plan. The shares originated from restricted stock unit vesting on October 2 and October 3, 2026. Muken has made previous sales under the same plan, and the company has 85,127,825 common shares outstanding.

Read original source

SOPH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.